Plant‐Derived Flavones as Inhibitors of Aurora B Kinase and Their Quantitative Structure–Activity Relationships

Although several plant‐derived flavones inhibit aurora B kinase (aurB), quantitative relationships between the structural properties of plant‐derived flavones and their inhibitory effects on aurB remain unclear. In this report, these quantitative structure–activity relationships were obtained. For quercetagetin, found in the Eriocaulon species, showing the best IC50 value among the flavone derivatives tested in this report, further biological tests were performed using cell‐based assays, including Western blot analysis, flow cytometry, and immunofluorescence microscopy. In vitro cellular experiments demonstrated that quercetagetin inhibits aurB. The molecular‐binding mode between quercetagetin and aurB was elucidated using in silico docking. Quercetagetin binds to aurB, aurA, and aurC and prevents the active phosphorylation of all three aurora kinases. In addition, quercetagetin triggers mitotic arrest and caspase‐mediated apoptosis. These observations suggest that quercetagetin is an aurora kinase inhibitor. Induction of mitosis‐associated tumor cell death by quercetagetin is a promising strategy for developing novel chemotherapeutic anticancer agents.

[1]  Y. Lim,et al.  Polyphenols bearing cinnamaldehyde scaffold showing cell growth inhibitory effects on the cisplatin-resistant A2780/Cis ovarian cancer cells. , 2014, Bioorganic & medicinal chemistry.

[2]  R. Huber,et al.  Structural and functional analysis of the natural JNK1 inhibitor quercetagetin. , 2013, Journal of molecular biology.

[3]  Stephen S. Taylor,et al.  Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores , 2003, The Journal of cell biology.

[4]  H. Katayama,et al.  Aurora kinase inhibitors as anticancer molecules. , 2010, Biochimica et biophysica acta.

[5]  Y. Lim,et al.  Novel antimitotic activity of 2-hydroxy-4-methoxy-2',3'-benzochalcone (HymnPro) through the inhibition of tubulin polymerization. , 2013, Journal of agricultural and food chemistry.

[6]  B. Narasimhan,et al.  Synthesis, antimicrobial, anticancer evaluation and QSAR studies of 6-methyl-4-[1-(2-substituted-phenylamino-acetyl)-1H-indol-3-yl]-2-oxo/thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid ethyl esters. , 2012, European journal of medicinal chemistry.

[7]  S. Knapp,et al.  Crystal Structure of Human Aurora B in Complex with INCENP and VX-680 , 2012, Journal of medicinal chemistry.

[8]  W. Earnshaw,et al.  The cellular geography of Aurora kinases , 2003, Nature Reviews Molecular Cell Biology.

[9]  S. Eckhardt,et al.  Targeting nuclear kinases in cancer: development of cell cycle kinase inhibitors. , 2014, Pharmacology & therapeutics.

[10]  M. Nagasawa,et al.  Phospho-regulation of human protein kinase Aurora-A: analysis using anti-phospho-Thr288 monoclonal antibodies , 2006, Oncogene.

[11]  R. Mehra,et al.  Aurora kinases in head and neck cancer. , 2013, The Lancet. Oncology.

[12]  Y. Lim,et al.  Structural Properties of Polyphenols Causing Cell Cycle Arrest at G1 Phase in HCT116 Human Colorectal Cancer Cell Lines , 2013, International journal of molecular sciences.

[13]  Kaori Sasai,et al.  Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells. , 2004, Cell motility and the cytoskeleton.

[14]  Y. Lim,et al.  Flavonoids promoting HaCaT migration: I. Hologram quantitative structure-activity relationships. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[15]  J. Blagg,et al.  Aurora kinase inhibitors: novel small molecules with promising activity in acute myeloid and Philadelphia-positive leukemias , 2010, Leukemia.

[16]  R. U. Kadam,et al.  Cluster analysis and two-dimensional quantitative structure-activity relationship (2D-QSAR) of Pseudomonas aeruginosa deacetylase LpxC inhibitors. , 2006, Bioorganic & medicinal chemistry letters.

[17]  O. Kallioniemi,et al.  Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpoint. , 2009, Carcinogenesis.

[18]  Long Yu,et al.  3-Hydroxyflavone inhibits endogenous Aurora B and induces growth inhibition of cancer cell line , 2010, Molecular Biology Reports.

[19]  Y. Lim,et al.  Isoflavones inhibit the clonogenicity of human colon cancer cells. , 2012, Bioorganic & medicinal chemistry letters.

[20]  David Bebbington,et al.  VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo , 2004, Nature Medicine.

[21]  S. Sen,et al.  Dynamic association of a tumor amplified kinase, Aurora-A, with the centrosome and mitotic spindle. , 2003, Cell motility and the cytoskeleton.

[22]  Qiang Huang,et al.  The dietary flavonoid luteolin inhibits Aurora B kinase activity and blocks proliferation of cancer cells. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[23]  Erich A. Nigg,et al.  Cell division: Mitotic kinases as regulators of cell division and its checkpoints , 2001, Nature Reviews Molecular Cell Biology.

[24]  M. Borad,et al.  Aurora kinase inhibitors , 2007 .

[25]  B. Henrissat,et al.  The Structure of a Streptomyces avermitilis α-l-Rhamnosidase Reveals a Novel Carbohydrate-binding Module CBM67 within the Six-domain Arrangement* , 2013, The Journal of Biological Chemistry.

[26]  W. Earnshaw,et al.  Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins , 2009, Current opinion in cell biology.

[27]  M. Dimopoulos,et al.  Aurora kinases as targets for cancer therapy. , 2008, Cancer treatment reviews.

[28]  Oliver Gautschi,et al.  Aurora Kinases as Anticancer Drug Targets , 2008, Clinical Cancer Research.

[29]  Y. Lim,et al.  Chromenylchalcones showing cytotoxicity on human colon cancer cell lines and in silico docking with aurora kinases. , 2013, Bioorganic & medicinal chemistry.

[30]  I. Lossos,et al.  Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  C. Müller,et al.  Crystal structure of the human ecto-5'-nucleotidase (CD73): insights into the regulation of purinergic signaling. , 2012, Structure.

[32]  D. Bevan,et al.  Mutational and Structural Analysis of Aglycone Specificity in Maize and Sorghum β-Glucosidases* , 2003, Journal of Biological Chemistry.

[33]  J. Harborne,et al.  Quercetagetin and patuletin in Eriocaulon , 1969 .

[34]  J. Bischoff,et al.  The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis. , 1999, Trends in cell biology.

[35]  J. Swedlow,et al.  Aurora B regulates MCAK at the mitotic centromere. , 2004, Developmental cell.

[36]  Thomas Lengauer,et al.  Evaluation of the FLEXX incremental construction algorithm for protein–ligand docking , 1999, Proteins.

[37]  Y. Lim,et al.  A peptide produced by Pseudomonas tolaasi, tolaasin binds to metal ions , 2012 .

[38]  K. Kimura,et al.  Direct Association with Inner Centromere Protein (INCENP) Activates the Novel Chromosomal Passenger Protein, Aurora-C* , 2004, Journal of Biological Chemistry.

[39]  H. Saya,et al.  Autophosphorylation of a Newly Identified Site of Aurora-B Is Indispensable for Cytokinesis* , 2004, Journal of Biological Chemistry.

[40]  H. Saya,et al.  Aurora-A — A guardian of poles , 2005, Nature Reviews Cancer.

[41]  G.,et al.  Annexin V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis , 2000 .

[42]  Y. Lim,et al.  Benzochalcones bearing pyrazoline moieties show anti-colorectal cancer activities and selective inhibitory effects on aurora kinases. , 2013, Bioorganic & medicinal chemistry.

[43]  T. Ikezoe,et al.  CD34+/CD38− acute myelogenous leukemia cells aberrantly express Aurora kinase A , 2011, International journal of cancer.

[44]  J. Pouwels,et al.  The flavonoid eupatorin inactivates the mitotic checkpoint leading to polyploidy and apoptosis. , 2012, Experimental cell research.

[45]  F. Giles,et al.  Targeting aurora kinases in cancer treatment. , 2011, Current drug targets.

[46]  A. Zekri,et al.  Gene amplification and overexpression of Aurora-C in breast and prostate cancer cell lines. , 2012, Oncology research.